Duggan MA, Anderson WF, Altekruse S, Penberthy L, Sherman ME. The surveillance, epidemiology, and end results (SEER) program and pathology: toward strengthening the critical relationship. Am J Surg Pathol. 2016;40(12):e94–102.

Article  PubMed  PubMed Central  Google Scholar 

Kolářová I, Melichar B, Sirák I, Vaňásek J, Petera J, Horáčková K, et al. The role of adjuvant radiotherapy in the treatment of breast Cancer. Curr Oncol. 2024;31(3):1207–20.

Article  PubMed  PubMed Central  Google Scholar 

Harris MA, Savas P, Virassamy B, O’Malley MM, Kay J, Mueller SN, et al. Towards targeting the breast cancer immune microenvironment. Nat Rev Cancer. 2024;24(8):554–77.

Article  CAS  PubMed  Google Scholar 

Guo S, Yao Y, Tang Y, Xin Z, Wu D, Ni C, et al. Radiation-induced tumor immune microenvironments and potential targets for combination therapy. Signal Transduct Target Therapy. 2023;8(1):205.

Article  Google Scholar 

Beckers C, Pruschy M, Vetrugno I. Tumor hypoxia and radiotherapy: A major driver of resistance even for novel radiotherapy modalities. Seminars in Cancer Biology; Elsevier; 2024.

Xi Y, Chen L, Tang J, Yu B, Shen W, Niu X. Amplifying eat me signal by Immunogenic cell death for potentiating cancer immunotherapy. Immunol Rev. 2024;321(1):94–114.

Article  CAS  PubMed  Google Scholar 

Galluzzi L, Kepp O, Hett E, Kroemer G, Marincola FM. Immunogenic cell death in cancer: concept and therapeutic implications. J Translational Med. 2023;21(1):162.

Article  CAS  Google Scholar 

Galluzzi L, Guilbaud E, Schmidt D, Kroemer G, Marincola FM. Targeting Immunogenic cell stress and death for cancer therapy. Nat Rev Drug Discovery. 2024:1–16.

Pan H, Liu P, Zhao L, Pan Y, Mao M, Kroemer G, et al. Immunogenic cell stress and death in the treatment of cancer. Seminars in Cell & Developmental Biology; Elsevier; 2024.

Yatim N, Cullen S, Albert ML. Dying cells actively regulate adaptive immune responses. Nat Rev Immunol. 2017;17(4):262–75.

Article  CAS  PubMed  Google Scholar 

Daguenet E, Louati S, Wozny A, Vial N, Gras M, Guy J, et al. Radiation-induced bystander and abscopal effects: important lessons from preclinical models. Br J Cancer. 2020;123(3):339–48.

Article  PubMed  PubMed Central  Google Scholar 

Craig DJ, Nanavaty NS, Devanaboyina M, Stanbery L, Hamouda D, Edelman G, et al. The abscopal effect of radiation therapy. Future Oncol. 2021;17(13):1683–94.

Article  CAS  PubMed  Google Scholar 

Theelen WS, de Jong MC, Baas P. Synergizing systemic responses by combining immunotherapy with radiotherapy in metastatic non-small cell lung cancer: the potential of the abscopal effect. Lung Cancer. 2020;142:106–13.

Article  PubMed  Google Scholar 

Dagar G, Gupta A, Shankar A, Chauhan R, Macha MA, Bhat AA, et al. The future of cancer treatment: combining radiotherapy with immunotherapy. Front Mol Biosci. 2024;11:1409300.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Labani-Motlagh A, Ashja-Mahdavi M, Loskog A. The tumor microenvironment: a milieu hindering and obstructing antitumor immune responses. Front Immunol. 2020;11:940.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakamura H, Takada K. Reactive oxygen species in cancer: current findings and future directions. Cancer Sci. 2021;112(10):3945–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang S, Liu G, Li Y, Pan Y. Metabolic reprogramming induces macrophage polarization in the tumor microenvironment. Front Immunol. 2022;13:840029.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Munir MT, Kay MK, Kang MH, Rahman MM, Al-Harrasi A, Choudhury M, et al. Tumor-associated macrophages as multifaceted regulators of breast tumor growth. Int J Mol Sci. 2021;22(12):6526.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tay C, Tanaka A, Sakaguchi S. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy. Cancer Cell. 2023;41(3):450–65.

Article  CAS  PubMed  Google Scholar 

Mortazavi Farsani SS, Verma V. Lactate mediated metabolic crosstalk between cancer and immune cells and its therapeutic implications. Front Oncol. 2023;13:1175532.

Article  PubMed  PubMed Central  Google Scholar 

Zetrini AE, Lip H, Abbasi AZ, Alradwan I, Ahmed T, He C, et al. Remodeling tumor immune microenvironment by using polymer-lipid-manganese dioxide nanoparticles with radiation therapy to boost immune response of castration-resistant prostate cancer. Research. 2023;6:0247.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Calcinotto A, Filipazzi P, Grioni M, Iero M, De Milito A, Ricupito A, et al. Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. Cancer Res. 2012;72(11):2746–56.

Article  CAS  PubMed  Google Scholar 

Maj T, Wang W, Crespo J, Zhang H, Wang W, Wei S, et al. Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor. Nat Immunol. 2017;18(12):1332–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roux C, Jafari SM, Shinde R, Duncan G, Cescon DW, Silvester J et al. Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1. Proceedings of the National Academy of Sciences. 2019;116(10):4326–35.

Jo Y, Shim JA, Jeong JW, Kim H, Lee SM, Jeong J, et al. Targeting ROS-sensing Nrf2 potentiates anti-tumor immunity of intratumoral CD8 T and CAR-T cells. Mol Ther. 2024;32(11):3879–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang L, Kuang Z, Zhang D, Gao Y, Ying M, Wang T. Reactive oxygen species in immune cells: A new antitumor target. Biomed Pharmacother. 2021;133:110978.

Article  CAS  PubMed  Google Scholar 

Abbasi AZ, Gordijo CR, Amini MA, Maeda A, Rauth AM, DaCosta RS, et al. Hybrid manganese dioxide nanoparticles potentiate radiation therapy by modulating tumor hypoxia. Cancer Res. 2016;76(22):6643–56.

Article  CAS  PubMed  Google Scholar 

Gordijo CR, Abbasi AZ, Amini MA, Lip HY, Maeda A, Cai P, et al. Design of hybrid MnO2-Polymer‐Lipid nanoparticles with tunable oxygen generation rates and tumor accumulation for Cancer treatment. Adv Funct Mater. 2015;25(12):1858–72.

Article  CAS  Google Scholar 

Prasad P, Gordijo CR, Abbasi AZ, Maeda A, Ip A, Rauth AM, et al. Multifunctional albumin–MnO2 nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response. ACS Nano. 2014;8(4):3202–12.

Article  CAS  PubMed  Google Scholar 

Rockwell S. In vivo-in vitro tumor systems: new models for studing the response of tumours to therapy. Lab Anim Sci. 1977;27(5 Pt 2):831–51.

CAS  PubMed  Google Scholar 

Lv D, Zhang Y, Kim H, Zhang L, Ma X. CCL5 as a potential immunotherapeutic target in triple-negative breast cancer. Cell Mol Immunol. 2013;10(4):303–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pulaski BA, Ostrand-Rosenberg S. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7. 1 cell-based tumor vaccines. Cancer Res. 1998;58(7):1486–93.

CAS  PubMed  Google Scholar 

Muz B, De La Puente P, Azab F, Kareem Azab A. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia. 2015:83–92.

Colombo G, Clerici M, Garavaglia ME, Giustarini D, Rossi R, Milzani A, et al. A step-by-step protocol for assaying protein carbonylation in biological samples. J Chromatogr B. 2016;1019:178–90.

Article  CAS  Google Scholar 

Boulefour W, Rowinski E, Louati S, Sotton S, Wozny A, Moreno-Acosta P, et al. A review of the role of hypoxia in radioresistance in cancer therapy. Med Sci Monitor: Int Med J Experimental Clin Res. 2021;27:934116.

Google Scholar